Dishing The Science with Dr. Sue
Thanks for tuning in! I'm a medical doctor and Specialist in Endocrinology and Metabolism in Canada, and I'm also certified as a Diplomate of the American Board of Obesity Medicine.
Why do I blog and podcast about weight management, obesity, and diabetes? Well, there is a LOT of misinformation out there, so I'm here to provide a resource that you (as a person/patient or as a health care provider) can trust! I bring to you hot topics, new science, and breaking news, with some mythbusting mixed in too! With over 20 years (and counting) of experience as a physician, I always report, share, and interpret the information with the person living with obesity or diabetes as the focus. With nearly 3 million hits on my blog to date, I am sure you will find something important to you/your patients. I'm excited to share this journey with you!
Episodes
106 episodes
What did the World Health Organization say about GLP1 obesity medicines?
The World Health Organization (WHO) has released a guideline on the use of GLP-1 medications, which is getting lots of attention worldwide. I have some mixed feelings about what they said - find out more here!Learn more:
•
4:25
'Ozempic in a pill' not effective for Alzheimer's disease
GLP1-based medications have many health benefits - but based on this recent study of oral semaglutide, preventing progression of Alzheimer's doesn't seem to be one of those benefits. Find out more about topline results here. L...
•
4:15
How fast is too fast? Weight loss with weight loss medications
While some people may be excited to lose as much weight as fast as possible with weight loss medication, there are a number of reasons why faster weight loss is NOT better weight loss. So how fast is too fast? Find out here!Learn m...
•
5:49
Headlines: is faster and greater weight loss a good thing?
News headlines applaud weight loss medications that give the BIGGEST or FASTEST weight loss. But is greater or faster weight loss actually better? Learn more:
•
6:08
Amylin: the next hormone-based weight management medications?
Some people don't tolerate GLP-1 medications, or need something more for weight loss. Could amylin agonists be the next hormone-based weight loss medications that could fill these gaps? Learn more:
•
4:41
What women need to know: Polycystic ovary syndrome, Perimenopause, and MASLD/MASH ('Fatty Liver')
Did you know that women with polycystic ovary syndrome, as well as women in perimenopause or menopause, are at increased risk of MASLD/MASH (formerly known as fatty liver disease)? Find out more here!Learn more:
•
4:25
Why people with obesity are denied joint replacement surgery – and what is being done to fix it
Why are people with obesity denied joint replacement surgery - and what is being done to fix it? Way to go Obesity Canada!Learn more:
•
3:55
Online weight loss medication: are you getting the treatment you need?
Online websites that prescribe weight management medication are becoming increasingly accessible and popular. Here are some of the checkpoints to make sure you are getting the care you need and deserve. Learn more:
•
5:41
Can GLP-1 medications cause funky skin sensations (dysesthesia)?
Can GLP-1 medications cause altered skin sensations? Find out what we know here.Learn more: https://drsue.ca/2025/10/can-glp-1-medications-...
•
4:45
Wading through all the ways to diagnose obesity - can we find our way to a simple common ground?
Obesity expert groups around the world have created guidance documents to reframe the diagnosis and assessment of obesity, to look beyond BMI, and embracing weight-related health issues, which differ in their approaches. Today I'm talking about...
•
5:09
Do weight management medications improve Quality of life?
Improving quality of life is a central goal in successful weight management. Do weight loss medications improve quality of life? Are there situations where quality of life could get worse, rather than better? Learn more:
•
4:13
GLP-1 in a pill for weight loss - pinning down where we're at
While we now have several injectable GLP-1s based treatments for weight management around the world [liraglutide (Saxenda), semaglutide (Wegovy), tirzepatide (Zepbound/Mounjaro)], there are no GLP-1s currently available in a pill format for obe...
•
7:39
Does everyone with type 2 diabetes need to be screened for MASH/MASLD (‘fatty liver’)? What the new Diabetes Canada Guidelines recommend
Two out of three people with type 2 diabetes have 'fatty liver disease' (now called MASH/MASLD). Should everyone with prediabetes or type 2 diabetes be screened? Find out what the brand new Diabetes Canada Guidelines say here!Learn...
•
6:11
Could metformin improve knee osteoarthritis pain?
Metformin has lots of benefits, including a reduction in inflammation. Is the reduction in inflammation enough to reduce pain in knee osteoarthritis? Learn more:
•
3:51
Do GLP1 based weight management medications benefit liver health?
Can semaglutide (Wegovy), tirzepatide (Mounjaro/Zepbound), or liraglutide (Saxenda) benefit liver health - and what did we recommend in our new 2025 Obesity Canada Pharmacotherapy Clinical Practice Guidelines? Find out here!Learn more: <...
•
5:11
What happens if you stop weight management medication, and what do our new Obesity Canada Guidelines advise?
Some people on weight management medication may want to stop treatment because of cost, or perhaps because they want to again try 'doing it on their own'. What do our new Obesity Canada 2025 Clinical Practice Guidelines recommend on this topic?...
•
5:29
OBESITY CANADA 2025 PHARMACOTHERAPY GUIDELINES: WHAT COULDN’T WE ANSWER?
In our NEW 2025 Obesity Canada Pharmacotherapy Clinical Practice Guidelines, we identified many existing gaps where data is lacking. Where did our Guidelines leave us wanting for more? Where is more research needed? Find out here!Learn m...
•
4:20
OBESITY CANADA PHARMACOTHERAPY clinical practice GUIDELINES 2025 – PUBLISHED!
As the lead author, I am thrilled to ANNOUNCE publication of our long-awaited 2025 Obesity Canada Clinical Practice Guidelines! Includes 13 recommendations, a brand new Decision Tool&Table to guide in the choice of medication, Key Mes...
•
4:51
Can weight loss medications improve erectile dysfunction (ED)?
Erectile dysfunction (ED) is common in men with elevated weight. Can weight loss medications improve ED?Learn more: https://drsue.ca/2025/08/...
•
5:20
How does Mounjaro stack up for cardiovascular protection? The SURPASS CVOT results
In choosing the best GLP1-based medication for our patients with type 2 diabetes at high risk of cardiovascular disease, guidelines recommend choosing one that has proven reduction in risk of CV events in cardiovascular outcome trials (CVOTs). ...
•
5:56
Can creatine supplements preserve muscle during weight loss?
Can creatine supplements preserve muscle during weight loss? Learn more: https://drsue.ca/2025/07/can-creatine-supplements-preserve-musc...
•
3:45
Sleep is a nutrient!
We often talk about sleep as a luxury in our busy lives. But what if we redefined sleep entirely? What if we thought of sleep like an essential vitamin – non-negotiable, restorative, and vital? It’s time we start seeing sleep as a nutrient....
•
4:10
Could GLP1 weight loss/diabetes medications benefit skin conditions like psoriasis or hidradenitis suppurativa?
As we gain 20+ years of experience with GLP1-based treatment, I continue to be fascinated by the diversity of potential benefits that we are finding in clinical trials and in clinical practice. A fascinating article was recently published...
•
4:34
Will once-a-month weight loss medication be a next big step forward?
Could the next generation of weight management medications include treatments given just once a month? Find out more here!Learn more:
•
4:44
Wegovy Plus Amylin: CagriSema weight management results revealed!
I was honored to present results of CagriSema - Wegovy+Amylin (cagrilintide) - as an up-and-coming weight managment medication at the American Diabetes Association meeting yesterday, with simultaneous publication of our results in the New Engla...
•
8:33